Abstract:Human cerebrospinal fluid (CSF), produced by the choroid plexus and secreted into the brain ventricles and subarachnoid space, plays critical roles in intra-cerebral transport and the biophysical and immune protection of the central nervous system (CNS). CSF composition provides valuable insight into soluble pathogenic bio-markers that may be diagnostic for neurodegenerative disease. In these experiments we analyzed amyloid beta (Aβ) peptide and micro RNA (miRNA) abundance (i) in CSF, (ii) in short post-mortem interval brain tissue-derived extracellular fluid (ECF) and (iii) in brain tissue biopsy derived from Alzheimer's disease (AD) or age-matched control neocortex and/or hippocampal CA1. 3'-untranslated region (3'-UTR) sequence/vector analysis; Aβ42-peptide+TNFα-induced and/or hydrogen peroxide-induced stress; bioinformatics; CAPE, CAY10512, DNA array; DNA/RNA sequencing; human brain biopsy/postmortem tissue; human CSF;LED-Northern micro-dot blot analysis; micro-RNA array; protected anti-miRNAs; RT-PCR; statistical analysis, β-actin, TREM-2- and CFH-3'-UTR-luciferase-reporter transfection assay; UV/fluorescent microscopy; Western immuno-histochemistry. There was a trend for decreased-abundance of Aβ42 in the CSF and ECF in AD but it did not reach statistical significance (mean-age ∼72 yr; N=12; p∼0.06, ANOVA). The most abundant nucleic acids in AD-CSF and ECF were miRNAs and their speciation, abundance and inducibility were studied further. Comparison of miRNA signals between biopsy and post-mortem tissues (0.5–6 hrs) indicated a short half-life for many brain-enriched miRNAs. Fluorescent miRNA-array-based analysis indicated significant increases in miRNA-9, miRNA-34a, miRNA-125b, miRNA-146a and miRNA-155. Increases in miRNAs were confirmed independently using a highly-sensitive LED-Northern dot-blot assay. Primary human neuronal-glial cell co-cultures stressed with AD-derived ECF, TNFα or peroxide also displayed an up-regulation of these and other miRNAs. These effects were quenched using the anti-NF-КB agents caffeic acid-phenethyl-ester (CAPE) or 1-fluoro-2-[2-(4-methoxy-phenyl)-ethenyl]-benzene (CAY10512). The results indicate that miRNA-9, miRNA-34a, miRNA-125b, miRNA-146a and miRNA-155 are a family of inducible, NF-КB-sensitive pro-inflammatory miRNAs that are abundant in AD tissues and fluids. These AD-upregulated miRNAs further associate with deficits in the innate-immune response and the chronic and progressive spreading of inflammatory neurodegeneration. Enrichment of these miRNAs in circulating CSF and ECF suggest that they may be involved in the proliferation of miRNA-triggered pathogenic signaling throughout the AD brain and CNS.

Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease.

Identification of Candidate Biomarkers of Alzheimer's Disease Via Multiplex Cerebrospinal Fluid and Serum Proteomics.

Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders.

Profiling of Serum Exosome MiRNA Reveals the Potential of a MiRNA Panel as Diagnostic Biomarker for Alzheimer’s Disease

Serum Exosomal miRNAs as Biomarkers of Early Diagnosis and Progression in Parkinson's Disease

Biological Function Analysis of MicroRNAs and Proteins in the Cerebrospinal Fluid of Patients with Parkinson's Disease

miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer’s disease and other types of dementia – an exploratory study

Aberrant Expression of Circulating MicroRNA Leads to the Dysregulation of Alpha-Synuclein and Other Pathogenic Genes in Parkinson's Disease

Central Nervous System-Derived Exosomal Alpha-Synuclein in Serum May Be a Biomarker in Parkinson's Disease.

Exosomal Mirnas in Central Nervous System Diseases: Biomarkers, Pathological Mediators, Protective Factors and Therapeutic Agents.

MicroRNA Expressing Profiles in A53T Mutant Alpha-Synuclein Transgenic Mice and Parkinsonian

Genome-wide Analysis of Mirna Signature in the APPswe/PS1ΔE9 Mouse Model of Alzheimer's Disease.

Different Patterns of Exosomal Α‐synuclein Between Parkinson's Disease and Probable Rapid Eye Movement Sleep Behavior Disorder

MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson’s Disease and Multiple System Atrophy

Differential Expression and Significance of Mirnas in Plasma Extracellular Vesicles of Patients with Parkinson's Disease.

MiR-184 Mediated the Expression of ZNF865 in Exosome to Promote Procession in the PD Model

Preliminary Study of Hsa-Mir-626 Change in the Cerebrospinal Fluid of Parkinson's Disease Patients.

Proteomic Profiling of Circulating Plasma Exosomes Reveals Novel Biomarkers of Alzheimer’s Disease

MicroRNA Complexity in Alzheimer's Disease Cerebrospinal Fluid, Extracellular Fluid and Brain Tissue Biopsy

Circulating MicroRNAs and Long Non-coding RNAs as Potential Diagnostic Biomarkers for Parkinson’s Disease

Microrna (mirna) Speciation in Alzheimer's Disease (AD) Cerebrospinal Fluid (CSF) and Extracellular Fluid (ECF).